Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2. This indicates a backend software release tag rather than a change to study data or user-facing content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedFooter revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check50 days agoChange DetectedAdds Hepatocellular carcinoma as a keyword and introduces a Genetics and Rare Diseases Information Center resource reference. These changes enhance disease context and provide an additional information resource for users.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page. No study content or functionality appears altered.SummaryDifference0.1%

- Check86 days agoChange DetectedThe update adds Revision: v3.4.2. The funding-status notice and the older Revision: v3.4.1 have been removed.SummaryDifference0.5%

Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.